Jovianna DiCarlo, a bio-pharmaceutical and Internet technology executive brings two decades of industry leadership experience across a spectrum of key corporate and strategic functions within the mHealth, Healthcare IT/ clinical informatics, pharmaceutical & biotechnology R &D, and medical device sectors throughout the global marketplace. Prior to joining 21WebIR she worked withprivate equity & venture capital firms as a life science clinical development & technology valuation M&A SME providing strategy driven translational asset development & risk management solutions to accelerate growth & sustain momentum of early stage companies.

Ms. DiCarlo also served as President & CEO of Consent Solutions, Inc.(Washington DC) a provider of web-based SaaS clinical trial informed consent (eIC) technology application where she accelerated value proposition for the company to attract investors generating two acquisition offers within 12 months. Jovianna alsoserved as President of eStudyBinder, LLC., (Toronto) where she led the accelerated development of internal & external business infrastructure & operations, product branding, business plan, global commercialization & launch strategy and successfully launched a web-based SaaS clinical trial regulatory management technology platform.